Clovis Oncology Announces Availability of Rubraca (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Germany
BOULDER, Colo. & MUNICH--(BUSINESS WIRE)--Mar 4, 2019--Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that Rubraca (rucaparib) is now available by prescription in Germany as…
